ClinVar Miner

Submissions for variant NM_000531.6(OTC):c.67C>T (p.Arg23Ter)

dbSNP: rs72552300
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001802797 SCV000884272 pathogenic Ornithine carbamoyltransferase deficiency 2021-07-01 criteria provided, single submitter clinical testing The OTC c.67C>T; p.Arg23Ter variant (rs72552300) is reported in the literature in individuals affected with ornithine transcarbamylase deficiency (Grompe 1991, Wilnai 2018). This variant is reported in ClinVar (Variation ID: 97292), and is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Grompe M et al. Improved molecular diagnostics for ornithine transcarbamylase deficiency. Am J Hum Genet. 1991 Feb;48(2):212-22. Wilnai Y et al. Prenatal treatment of ornithine transcarbamylase deficiency. Mol Genet Metab. 2018 Mar;123(3):297-300.
Labcorp Genetics (formerly Invitae), Labcorp RCV001802797 SCV002238574 pathogenic Ornithine carbamoyltransferase deficiency 2022-08-03 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 97292). This premature translational stop signal has been observed in individual(s) with ornithine transcarbamylase deficiency (PMID: 1671317, 18604903). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg23*) in the OTC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OTC are known to be pathogenic (PMID: 10946359, 16786505).
GeneDx RCV000083537 SCV003852982 pathogenic not provided 2023-03-31 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 10946359, 24485820, 1671317, 18604903, 29396029, 9286441, 11793468, 11117428, 25433810, 19138872, 33489762, 33309754, 33272297, 32778825)
Juno Genomics, Hangzhou Juno Genomics, Inc RCV001802797 SCV005417154 pathogenic Ornithine carbamoyltransferase deficiency criteria provided, single submitter clinical testing PM2_Supporting+PVS1+PS2_Moderate+PS4
GenMed Metabolism Lab RCV000083537 SCV000115623 pathogenic not provided no assertion criteria provided not provided Converted during submission to Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.